Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $250.68 | 13 | 92.8% |
| Gift | $19.40 | 1 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $77.49 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $74.58 | 4 | $0 (2023) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Harrow Eye, LLC | $18.74 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $18.69 | 1 | $0 (2024) |
| Oyster Point Pharma, Inc. | $17.03 | 1 | $0 (2023) |
| Thea Pharma Inc. | $16.61 | 1 | $0 (2023) |
| Alcon Vision LLC | $14.09 | 1 | $0 (2023) |
| TissueTech, Inc. | $13.45 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.43 | 2 | Harrow Eye, LLC ($18.74) |
| 2023 | $163.69 | 8 | Regeneron Healthcare Solutions, Inc. ($77.49) |
| 2022 | $22.41 | 1 | Novartis Pharmaceuticals Corporation ($22.41) |
| 2021 | $13.70 | 1 | Novartis Pharmaceuticals Corporation ($13.70) |
| 2020 | $19.40 | 1 | Carl Zeiss Meditec AG ($19.40) |
| 2019 | $13.45 | 1 | TissueTech, Inc. ($13.45) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: OPTOMETRY | ||||||
| 03/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Ophthalmology | ||||||
| 10/31/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/18/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: DRY EYE | ||||||
| 07/18/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/19/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Ophthalmology | ||||||
| 04/03/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Ophthalmology | ||||||
| 03/21/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/06/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Ophthalmology | ||||||
| 10/17/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/08/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 08/12/2019 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: Medical Device (510K) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,079 | 3,321 | $446,464 | $213,068 |
| 2022 | 19 | 2,589 | 4,228 | $565,350 | $282,535 |
| 2021 | 17 | 2,318 | 3,956 | $548,595 | $256,585 |
| 2020 | 16 | 1,359 | 2,616 | $366,895 | $151,775 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92499 | Other service or procedure on eye | Office | 2022 | 181 | 326 | $22,830 | $9,004 | 39.4% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2022 | 112 | 336 | $30,240 | $7,712 | 25.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 51 | 134 | $12,610 | $7,222 | 57.3% |
| 92250 | Photography of the retina | Office | 2022 | 223 | 232 | $18,590 | $5,854 | 31.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 128 | 129 | $10,985 | $5,668 | 51.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $10,200 | $5,331 | 52.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 22 | 33 | $4,135 | $3,110 | 75.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 104 | 106 | $5,390 | $2,596 | 48.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 28 | $1,680 | $1,223 | 72.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 14 | 15 | $1,350 | $999.82 | 74.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 16 | 17 | $850.00 | $346.70 | 40.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 24 | 24 | $480.00 | $195.06 | 40.6% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 84 | 140 | $133,600 | $59,126 | 44.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 357 | 479 | $45,505 | $32,312 | 71.0% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2021 | 91 | 125 | $54,810 | $32,300 | 58.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 212 | 289 | $37,570 | $27,583 | 73.4% |
| 83861 | Microfluid analysis of tears | Office | 2021 | 343 | 776 | $19,400 | $17,411 | 89.7% |
| 67028 | Injection of drug into eye | Office | 2021 | 54 | 186 | $95,580 | $16,139 | 16.9% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 213 | 434 | $28,210 | $13,003 | 46.1% |
| 92499 | Service or surgery of the eye | Office | 2021 | 194 | 401 | $28,340 | $12,145 | 42.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 53 | 179 | $17,900 | $10,202 | 57.0% |
| 76519 | Ultrasound of eye for determination of lens power | Office | 2021 | 95 | 277 | $24,960 | $6,899 | 27.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 64 | 88 | $11,540 | $6,665 | 57.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 109 | 125 | $11,435 | $5,622 | 49.2% |
| 92250 | Photography of the retina | Office | 2021 | 199 | 207 | $17,595 | $5,471 | 31.1% |
About Dr. Michael Vittone, MD
Dr. Michael Vittone, MD is a Ophthalmology healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104879238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Vittone, MD has received a total of $270.08 in payments from pharmaceutical and medical device companies, with $37.43 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($250.68).
As a Medicare-enrolled provider, Vittone has provided services to 8,345 Medicare beneficiaries, totaling 14,121 services with total Medicare billing of $903,962. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Latrobe, PA
- Active Since 05/18/2006
- Last Updated 06/13/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1104879238
Products in Payments
- XIIDRA (Drug) $74.58
- EYLEA (Biological) $55.22
- EYLEA HD (Biological) $22.27
- None Specified (Medical Supply) $19.40
- VEVYE (Drug) $18.74
- Izervay (Drug) $18.69
- TYRVAYA (Drug) $17.03
- IYUZEH (Drug) $16.61
- Rocklatan (Drug) $14.09
- Prokera (Device) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.